Truemeds
PrivateLast Round
Series C
Aug 11, 2025
Est. Valuation
$400M
Total Funding Raised
$112.49M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Truemeds is a healthtech company that operates an e-pharmacy and telehealth platform providing affordable, clinically equivalent generic alternatives to branded medications.
Sector
Healthcare & Life Sciences
Verticals
E-commerce, Telemedicine, D2C Brands, Pharma Supply Chain
Business Model
B2C
Customer Profile
Marketplace Commission, Hardware Sales, Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Truemeds Comparables
Compare Truemeds with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PharmEasy | 87% | |
| PlatinumRx | 86% | |
| Zeno Health | 85% | |
Truemeds Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 11, 2025 | ||||
| Series B | Apr 26, 2022 | ||||
| Series A | Jun 8, 2021 | ||||
| Seed | May 22, 2020 |
Key People
Founding team and executive leadership
Truemeds Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IAN Group | Series B, Series A |
| Peak XV Partners | Series C |
| Info Edge Ventures | Series B, Series C, Series A, Seed |
| Inception Studio Capital | Series B |
| WestBridge Capital | Series C, Series B |
| Asha Ventures | Series B, Series A |
| Accel | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Actor Paresh Rawal featured in upcoming campaign.
- Jan 1, 2026
Achieved 3.6x growth in revenue over two years.
Truemeds Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Truemeds's valuation, stock price, and market status.